ArticleScientific reports2025
Outcome of universal newborn hearing screening conducted in three referral hospitals in Cameroon.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Universal newborn hearing screening in Southwest Iran: coverage, risk factors, and outcomes in a large-scale population.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026Article
- Newborn hearing screening: outcomes and management of infants.Revista da Associacao Medica Brasileira (1992) · 2026Article
- Pediatric hearing loss in the universal newborn hearing screening era: etiologies, risk indicators, and clinical phenotypes.Frontiers in public health · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Universal newborn hearing screening (UNHS) is recommended for early identification of congenital hearing impairment (CHI). Evidence has shown that much of the impact of this condition can be mitigated through early detection and intervention. We sought to report findings of UNHS in a setting where it is not effectively implemented, describe the risk profile of potentially hearing impaired babies after screening, and determine factors associated with abnormal results. This was a hospital-based cross-sectional study carried out in three reference hospitals in Cameroon, for a period of three months from January to March 2024. We included all neonates born or admitted in any of these three facilities. Critically ill babies were excluded. A portable non-invasive otoacoustic emission (OAE) device was used. This device is exclusively used for screening, not diagnosis. Results were either "pass" or "refer", indicating that OAEs were either recorded or not detected respectively. A total of 215 babies were screened. Fifty-three out of 215 newborns had abnormal results (24.7%). Maternal age varied from 13 to 41 years, with a mean of 27.6 years. Among newborns with abnormal OAE results, maternal risk factors found were maternal alcoholism (23; 43.4%), family history of hearing loss (9; 17%), and infections (3; 5.7%). Neonatal risk factors were gentamicin administration (33; 62.3%), acute foetal distress/ neonatal asphyxia (19; 35.8%), and meningitis (7; 13.2%). Statistically significant risk factors identified on multivariate analysis included maternal alcoholism (adjusted OR 3.5, 95% CI 1.6-7.8, p = 0.002), the use of gentamicin (adjusted OR 5, 95% CI 2.3-10.8, p < 0.001), neonatal asphyxia (adjusted OR 3.3, 95% CI 1.2-6.4, p < 0.001), and meningitis (adjusted OR 6.3, 95% CI 1.1-35.7, p = 0.04). Without UNHS, many children with CHI are probably missed at the time when they would benefit most from treatment. Despite the cost-effectiveness of screening methods, and the availability of hearing specialists in some hospitals in Cameroon, UNHS is still not implemented. Risk factors for CHI are common among babies born in Cameroon. Diagnosis and management of CHI should be preceded by preventive measures, which include good perinatal care and satisfactory control of risk factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.